Literature DB >> 7605935

Quantitation of mu-opioid receptor (MOR-1) mRNA in selected regions of the rat CNS.

M Brodsky1, K Elliott, A Hynansky, S Jenab, C E Inturrisi.   

Abstract

The mu opioid receptor (MOR-1) mRNA was quantified in rat CNS by a sensitive solution hybridization (SH) technique, employing a 32P-labeled riboprobe derived from the coding region of MOR-1 cDNA. In a Northern blot analysis this riboprobe hybridized to a 14 kb form of rat MOR-1 mRNA. The linear range of SH assay extends from 1 to 250 pg of MOR-1 sense transcript (equivalent to 9.3-2325 pg of MOR-1 mRNA). A microdissection technique for reproducible sampling of selected CNS regions, followed by the SH assay, allowed for a quantitative study of MOR-1 mRNA distribution. The highest levels of MOR-1 mRNA were present in medial thalamus (17.8 +/- 0.3 pg/micrograms RNA), and the lowest in the cerebellum (0.4 +/- 0.1 pg/microgram RNA). Hypothalamus, dorsal spinal horn, nucleus raphe, periaqueductal gray, and sensorimotor cortex contained intermediate levels. This distribution closely parallels the pattern of mu receptor binding, suggesting that both the mRNA and the receptor protein are colocalized within most of the regions studied.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605935     DOI: 10.1097/00001756-199503270-00005

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

Review 1.  MicroRNAs in opioid pharmacology.

Authors:  Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-09       Impact factor: 4.147

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  Stabilization of morphine tolerance with long-term dosing: association with selective upregulation of mu-opioid receptor splice variant mRNAs.

Authors:  Jin Xu; Andrew J Faskowitz; Grace C Rossi; Mingming Xu; Zhigang Lu; Ying-Xian Pan; Gavril W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

4.  Interleukin-6 regulation of kappa opioid receptor gene expression in primary sertoli cells.

Authors:  S Jenab; P L Morris
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

5.  Regulation of rat MOR-1 gene expression after chronic intracerebroventricular administration of morphine.

Authors:  Zhi-Ping Zhu; Ramesh B Badisa; Donald E Palm; Carl B Goodman
Journal:  Mol Med Rep       Date:  2011-11-15       Impact factor: 2.952

6.  Mouse mu opioid receptor gene expression. A 34-base pair cis-acting element inhibits transcription of the mu opioid receptor gene from the distal promoter.

Authors:  C y Choe; H J Im; J L Ko; H H Loh
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

7.  MicroRNA 339 down-regulates μ-opioid receptor at the post-transcriptional level in response to opioid treatment.

Authors:  Qifang Wu; Cheol Kyu Hwang; Hui Zheng; Yadav Wagley; Hong-Yiou Lin; Do Kyung Kim; Ping-Yee Law; Horace H Loh; Li-Na Wei
Journal:  FASEB J       Date:  2012-10-19       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.